InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Benton Susan, Director. Insider active across 2 companies, notably Ocuphire Pharma, Inc.. Aggregated, 13 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €77k. Activity tracked since 2 September 2021. The latest transaction was filed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Benton Susan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
24,367 shares0Common StockSEC:0000905148-26-001784:0
79,504 shares0Common StockSEC:0000905148-25-001426:0
41,143 shares0Common StockSEC:0000905148-24-001710:0
19,418 sharesCommon StockSEC:0001140361-24-000491:0
10,976 shares0Common StockSEC:0001140361-23-029021:0
1,053 sharesCommon StockSEC:0001140361-23-019676:0
16,267 sharesCommon StockSEC:0001140361-23-001504:0
6,335 sharesCommon StockSEC:0001140361-22-025289:0
3,395 sharesCommon StockSEC:0001140361-22-013064:0
2,949 sharesCommon StockSEC:0001140361-22-000658:0
2,135 sharesCommon StockSEC:0001140361-21-033449:0
20,000 shares@ US$4.57100.0% of flowCommon StockSEC:0001140361-21-030364:0
Canonical exit: 1 Dec 2021 (T+90)
2,083 sharesCommon StockSEC:0001140361-21-023335:0
13 of 13 declarations
About Benton Susan
Benton Susan is Administrateur at Ocuphire Pharma, Inc. and Opus Genetics, Inc. She has 13 filings in total, and across the recent filings tracked, the reported activity consists of purchases of EUR 76959 and no sales, from 2021-07-02 to 2026-04-22. The most frequent transaction nature is Attribution.
